Neddylation and anti-tumor immunity
Metrics: PDF 46 views | Full Text 170 views | ?
Xiaoguang Wang1, Scott Best2 and Alexey V. Danilov1
1 Department of Hematology and Hematopoietic Stem Cell Transplant, City of Hope National Medical Center, Duarte, CA, USA
2 Molecular and Cellular Biology, University of Washington, Seattle, WA, USA
|Alexey V. Danilov,||email:||email@example.com|
Keywords: neddylation; T cell; pevonedistat
Received: June 10, 2021 Accepted: June 21, 2021 Published: PUBLISHED_DATE
Contrary to chemotherapy, novel targeted therapies are associated with diverse immunomodulatory effects. Nedd8 is a small ubiquitin-like modifier that is involved in regulation of protein degradation. Neddylation is a promising target in cancer. Pevonedistat, a small molecule inhibitor of the Nedd8-activating enzyme, demonstrates pre-clinical activity in multiple tumor types. Recent studies have revealed that neddylation is important in immunity. We and others have shown that interfering with neddylation causes downstream immunomodulatory effects potentially leading to enhanced anti-tumor immunity. Thus, Nedd8 is a promising target in immuno-oncology.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.